Anna Belser
Clinical Researcher
Papers
Trials
Key Impact
Notable for qualitative and conceptual contributions to the study of psilocybin-assisted psychotherapy, particularly in understanding patient experience and in advancing transdiagnostic psychotherapy models.
Background & Research
Anna Belser (publishes as A. B. Belser) is a clinical researcher whose work centres on the experiential, therapeutic and procedural aspects of psychedelic-assisted psychotherapy. Her publications focus on qualitative and small-sample clinical investigations of psilocybin-assisted therapy for cancer-related distress and anxiety, including detailed case series and interpretative phenomenological analyses that probe patients' subjective responses and meaning-making processes. Belser has explored the phenomenology of mystical-type experiences both inside and outside pharmacologically induced states and has contributed to methodological and theoretical work on models of psychedelic-assisted psychotherapy.
Her contributions extend beyond patient narratives to the pragmatic organisation of therapeutic approaches: she is an author on contemporary assessments of psychedelic-assisted psychotherapy models and an introducer to EMBARK, a transdiagnostic, trans-drug psychotherapy framework. Belser's research is characterised by rigorous qualitative methods, careful attention to clinical context in oncology settings, and an orientation toward translating subjective patient experiences into frameworks that inform therapeutic practice and trial design.